Detalles de la búsqueda
1.
Predicting Treatment Responses in Patients With Osteoarthritis: Results From Two Phase III Tanezumab Randomized Clinical Trials.
Clin Pharmacol Ther
; 113(4): 878-886, 2023 04.
Artículo
en Inglés
| MEDLINE | ID: mdl-36621827
2.
Historical Benchmarks for Quality Tolerance Limits Parameters in Clinical Trials.
Ther Innov Regul Sci
; 55(6): 1265-1273, 2021 11.
Artículo
en Inglés
| MEDLINE | ID: mdl-34453269
3.
The Interleukin-1 Receptor-Associated Kinase 4 Inhibitor PF-06650833 Blocks Inflammation in Preclinical Models of Rheumatic Disease and in Humans Enrolled in a Randomized Clinical Trial.
Arthritis Rheumatol
; 73(12): 2206-2218, 2021 12.
Artículo
en Inglés
| MEDLINE | ID: mdl-34423919
4.
TYK2/JAK1 Inhibitor PF-06700841 in Patients with Plaque Psoriasis: Phase IIa, Randomized, Double-Blind, Placebo-Controlled Trial.
J Invest Dermatol
; 140(12): 2359-2370.e5, 2020 12.
Artículo
en Inglés
| MEDLINE | ID: mdl-32311398
5.
Safety, tolerability, pharmacokinetics, and pharmacodynamics of PF-06650833, a selective interleukin-1 receptor-associated kinase 4 (IRAK4) inhibitor, in single and multiple ascending dose randomized phase 1 studies in healthy subjects.
Arthritis Res Ther
; 21(1): 269, 2019 12 05.
Artículo
en Inglés
| MEDLINE | ID: mdl-31805989
6.
Competition between Native Populus deltoides and Invasive Tamarix ramosissima and the Implications for Reestablishing Flooding Disturbance.
Conserv Biol
; 14(6): 1744-1754, 2000 Dec 18.
Artículo
en Inglés
| MEDLINE | ID: mdl-35701936
7.
A randomized comparison of bypassing agents in hemophilia complicated by an inhibitor: the FEIBA NovoSeven Comparative (FENOC) Study.
Blood
; 109(2): 546-51, 2007 Jan 15.
Artículo
en Inglés
| MEDLINE | ID: mdl-16990605
Resultados
1 -
7
de 7
1
Próxima >
>>